MOUNT RIDLEY MINES LTD(MRD.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

MRD.AU MOUNT RIDLEY MINES LTD

Market Closed 12-19 16:12:00 AEDT

0.03

+0.00

0.00%

High0.03	Low0.03	Vol10.81M
Open0.03	D1 Closing0.03	Amplitude12.90%
Mkt Cap38.78M	Tradable Cap33.20M	Total Shares1.25B
T/O345.85K	T/O Rate1.01%	Tradable Shares1.07B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MRD.AU","market":"AU","secType":"STK","nameCN":"MOUNT RIDLEY MINES LTD","latestPrice":0.031,"timestamp":1766121120000,"preClose":0.031,"halted":0,"volume":10807527,"delay":0,"nameEN":"MOUNT RIDLEY MINES LTD","floatShares":1070873553,"shares":1251075699,"eps":-0.0034,"marketStatus":"Market Closed","change":0,"latestTime":"12-19 16:12:00 AEDT","open":0.031,"high":0.034,"low":0.03,"amount":345849,"amplitude":0.129032,"askPrice":0.032,"askSize":694530,"bidPrice":0.031,"bidSize":6098,"shortable":3,"etf":0,"ttmEps":-0.0034,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766358000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.031,"openAndCloseTimeList":[[1766098800000,1766120400000]],"volumeRatio":1.596217,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/MRD.AU/wiki","defaultTab":"wiki","newsList":[{"id":"2592159302","title":"Bulls N’ Bears ASX Runners of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2592159302","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592159302?lang=en_us&edition=fundamental","pubTime":"2025-12-19 07:25","pubTimestamp":1766100345,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runners of the Year is… Kaili Resources which turned hot air and a tight Chinese register into a 396-bagger meme-stock frenzy in just 48 hours of absolute chaos.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-21059024/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-21059024/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/bulls-n-bears-asx-runners-of-the-year-c-21059024","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/bulls-n-bears-asx-runners-of-the-year-c-21059024","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["FML.AU","REE","BK7095","MRD.AU","FRS.AU","XJO.AU","BK7083","KLR.AU","FDR.AU","XAO.AU","BK7104","LKY.AU","BK7142","XKO.AU","DTR.AU","BK4124","BK7088","SRL.AU","REE.AU","MPW.AU"],"gpt_icon":0},{"id":"2586441616","title":"Mount Ridley Mines Says Geophysical Review Defines Seven Rare Earth Element, Gallium Target Zones at Western Australia Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2586441616","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586441616?lang=en_us&edition=fundamental","pubTime":"2025-11-25 14:17","pubTimestamp":1764051461,"startTime":"0","endTime":"0","summary":"Mount Ridley Mines  said a geophysical reinterpretation across the Mount Ridley project in Western Australia improved its understanding of the geological controls driving rare earth element and gallium mineralization and defined seven target zones at the project, according to a Tuesday Australian bourse filing.The target zones collectively form a 33-kilometer-long, untested corridor. The highest priority area is a 12.8-kilometer-long series of targets, east of the blocks that host the existing gallium resource.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","XJO.AU","BK7095","XAO.AU","BK4168","WRN","MRD.AU"],"gpt_icon":0},{"id":"2585426321","title":"Adaptive Biotechnologies (ADPT) Is Up 15.4% After Raising Guidance on Strong MRD Test Momentum Has the Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2585426321","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585426321?lang=en_us&edition=fundamental","pubTime":"2025-11-21 23:23","pubTimestamp":1763738590,"startTime":"0","endTime":"0","summary":"In the past week, Adaptive Biotechnologies reported third quarter results that surpassed market expectations, citing robust performance in its minimal residual disease (MRD) testing business led by the clonoSEQ test and supported by increased average selling prices.\nAn important insight from this update is management’s decision to raise full-year guidance, reflecting growing clinical adoption and sustained momentum for MRD testing across hematological cancers.\nTo understand the impact of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/adaptive-biotechnologies-adpt-is-up-154-after-raising-guidan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-adpt/adaptive-biotechnologies/news/adaptive-biotechnologies-adpt-is-up-154-after-raising-guidan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","BK7095","MRD.AU","ADPT"],"gpt_icon":0},{"id":"2584923761","title":"Mount Ridley Mines Appoints Allister Caird As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2584923761","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584923761?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:21","pubTimestamp":1763569314,"startTime":"0","endTime":"0","summary":"Nov 3 (Reuters) - Mount Ridley Mines Ltd ::*APPOINTMENT OF CHIEF EXECUTIVE OFFICER*ALLISTER CAIRD APPOINTED AS CEO*Further company coverage: MRD.AX* ((Reuters.Briefs@thomsonreuters.com;))  ((Reuters I","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDc3SnXc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRD.AU","BK7095"],"gpt_icon":0},{"id":"2584884611","title":"AI and Multi-omics are Transforming Cancer Care: APAC Precision Oncology Conference Outlines the Future of Early Detection and Personalized Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584884611","media":"prnewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584884611?lang=en_us&edition=fundamental","pubTime":"2025-11-17 13:45","pubTimestamp":1763358300,"startTime":"0","endTime":"0","summary":"HONG KONG, Nov. 17, 2025 /PRNewswire/ -- TheAPAC Precision Oncology Conference 2025, themed Artificial Intelligence  & Multi-omics in Cancer Management, convened in Hong Kong on November 1, marking Lung Cancer Awareness Month with a clear message: AI and multi-omics are no longer theoretical - they are driving real-world advancements in cancer care across the Asia-Pacificregion.The APAC Precision Oncology Conference 2025: 13 Distinguished Faculty Members. Multi-omics integrates diverse layers of biological data—such as DNA fragments, methylation patterns, copy number aberrations, and genetic mutations—to provide a more comprehensive view of cancer cells, not only found in tissue but also in blood samples. When harnessed with AI, these insights enable rapid, accurate analysis, empowering clinicians to detect cancer earlier, tailor personalized treatments, and monitor disease progression with unprecedented precision.","market":"sh","thumbnail":"https://mma.prnewswire.com/media/2824310/The_APAC_Precision_Oncology_Conference_2025___13_distinguished_faculty.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2824310/The_APAC_Precision_Oncology_Conference_2025___13_distinguished_faculty.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ai-and-multi-omics-are-transforming-cancer-care-apac-precision-oncology-conference-outlines-the-future-of-early-detection-and-personalized-treatment-302616653.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4543","BK4528","BK4588","BK7095","MRD.AU","BK4023","NGS.AU","BK4587","NGS","BK4179","BK4585","AI","BK7111"],"gpt_icon":0},{"id":"2582844790","title":"Jiahui International Cancer Center Attracts Global Patients with Advanced CAR-T Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2582844790","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582844790?lang=en_us&edition=fundamental","pubTime":"2025-11-10 14:09","pubTimestamp":1762754940,"startTime":"0","endTime":"0","summary":"SHANGHAI, Nov. 10, 2025 /PRNewswire/ -- On November 7, Jiahui International Cancer Center  successfully treated a 78-year-old patient from New Zealand with relapsed multiple myeloma using CAR-T therapy, highlighting JICC's growing reputation as a destination for cutting-edge oncology care for international patients. The patient received Zevor-cel  CAR-T therapy and was discharged in stable condition.78yr old New Zealand patient after CAR-T treatment . The patient, a retired family medicine doctor with 40 years of experience, had exhausted all conventional treatment options in his home country. Following a recommendation from his hematologist and extensive personal research, he chose JICC for Chimeric Antigen Receptor T-cell  therapy. China is a global leader in CAR-T development, ranking second only to the United States in clinical trials and patient volume, making it a key hub for this advanced treatment.\"The entire treatment process atJiahui was very professional, and I received meti","market":"other","thumbnail":"https://mma.prnewswire.com/media/2818277/78yr_New_Zealand_patient_CAR_T_treatment.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2818277/78yr_New_Zealand_patient_CAR_T_treatment.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/jiahui-international-cancer-center-attracts-global-patients-with-advanced-car-t-therapy-302609818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR","MRD.AU","BK7095","BK4022","BK4230"],"gpt_icon":0},{"id":"2581007879","title":"ASX Runners of the Week: Mont Royal, Mount Ridley, HitIQ & XPON","url":"https://stock-news.laohu8.com/highlight/detail?id=2581007879","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581007879?lang=en_us&edition=fundamental","pubTime":"2025-11-07 06:08","pubTimestamp":1762466907,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Mont Royal Resources, after it exploded back from merger purgatory with a Canadian rare earths relisting that looks turnkey ready.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-20607508/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20607508/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-mont-royal-mount-ridley-hitiq-xpon-c-20607508","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-mont-royal-mount-ridley-hitiq-xpon-c-20607508","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK4585","MRD.AU","XEC","LU0345780521.USD","BK7094","BK7104","BK4588","HIQ.AU","MRZ.AU","XPN.AU","BK7016","RGLD","LU0345780281.USD","BK4017","BK7095"],"gpt_icon":0},{"id":"2580918253","title":"BUZZ-Australia's Mount Ridley Mines hits 3-year high on appointing new CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2580918253","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580918253?lang=en_us&edition=fundamental","pubTime":"2025-11-03 09:18","pubTimestamp":1762132725,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mount Ridley Mines hits 3-year high on appointing new CEO** Mount Ridley Mines MRD.AX surges as much as 78.1% to A$0.054, highest since October 12, 2022** Rare earths explorer appoints Allister Caird as CEO** Caird previously served as head of critical minerals at copper and gold explorer Locksley Resources LKY.AX** Around 86.9 million shares traded, 6.4x the 30-day avg** MRD last up 75%, surging ~2,033% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL4N3WF01P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","LKY.AU","MRD.AU"],"gpt_icon":0},{"id":"2580623468","title":"Mount Ridley Mines Ltd - Allister Caird Appointed as CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2580623468","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580623468?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:43","pubTimestamp":1762123380,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE5N5R54:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRD.AU","BK7095"],"gpt_icon":0},{"id":"2580234682","title":"Mount Ridley Mines Ltd-Appointment of Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2580234682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580234682?lang=en_us&edition=fundamental","pubTime":"2025-11-03 06:43","pubTimestamp":1762123380,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251102:nTUE5N5R54:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","MRD.AU"],"gpt_icon":0},{"id":"2579434706","title":"ASX Runners of the Week: Mount Ridley, Eden, Whitebark & Pivotal Metals","url":"https://stock-news.laohu8.com/highlight/detail?id=2579434706","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579434706?lang=en_us&edition=fundamental","pubTime":"2025-10-31 06:45","pubTimestamp":1761864307,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Mount Ridley Mines, which unearthed a monster 24,584-tonne gallium resource from its WA clay rare earths project. ","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-20534933/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-20534933/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-mount-ridley-eden-whitebark-pivotal-metals-c-20534933","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-mount-ridley-eden-whitebark-pivotal-metals-c-20534933","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["TCF","EDE.AU","MRD.AU","BK7095","PVT.AU","BK7037","WBE.AU","BK7142","BK7083","TCF.AU"],"gpt_icon":0},{"id":"2578983834","title":"Mount Ridley Mines Identifies Major Gallium Resource at Namesake Project in WA","url":"https://stock-news.laohu8.com/highlight/detail?id=2578983834","media":"Small Caps","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578983834?lang=en_us&edition=fundamental","pubTime":"2025-10-28 12:56","pubTimestamp":1761627409,"startTime":"0","endTime":"0","summary":"Mount Ridley Mines has released a maiden gallium mineral resource estimate  for its namesake Mt Ridley project in Western Australia’s far south.The JORC-compliant mineral resource estimate  currently stands at 838.7 million tonnes at 29.3 parts per million for 24,584t, ranking it among the world’s largest known gallium resources.In anticipation of progressing the project’s development, the company has entered into discussions about the potential support of a US–Australia critical minerals supply chain.The MRE, which follows detailed and extensive desktop reviews, covers three separate zones at Mt Ridley.The central gallium “Block 1” zone – which has a strong correlation between high gallium and heavy rare earth elements  – contains an estimated inferred resource of 164.1Mt at 29.8ppm for 4,888t of contained gallium.The project’s location, close to established port, road, and power infrastructure, provides important logistical advantages for future development.","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Mount-Ridley-Mines-Major-Gallium-Resource-Namesake-Project-WA.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/10/Mount-Ridley-Mines-Major-Gallium-Resource-Namesake-Project-WA.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/mount-ridley-mines-major-gallium-resource-western-australia/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/mount-ridley-mines-major-gallium-resource-western-australia/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["XJO.AU","XKO.AU","BK7095","MRD.AU","MRE.AU","XAO.AU"],"gpt_icon":0},{"id":"2578696773","title":"Raffles Medical Group Partners Gene Solutions to Expand Access to Global Cancer Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2578696773","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578696773?lang=en_us&edition=fundamental","pubTime":"2025-10-27 13:22","pubTimestamp":1761542520,"startTime":"0","endTime":"0","summary":"SINGAPORE, Oct. 27, 2025 /PRNewswire/ -- Raffles Medical Group  and Gene Solutions have signed a Memorandum of Understanding  on 22 October 2025 to streamline patient recruitment for oncology clinical trials, marking a significant milestone in advancing precision medicine in Southeast Asia.[From left to right] Mr. Wilson Lai, General Manager of Raffles Medical Indochina and Dr. Nguyen Huu Nguyen, Co-founder and Deputy CEO of Gene Solutions.Under this partnership,the Group and Gene Solutions will collaborate to identify patients eligible for pharma-sponsored clinical trials. Patients undergoing Comprehensive Genomic Profiling  via Gene Solutions will be automatically screened for eligibility. The Group's Clinical Trials Unit will collaborate closely with local oncologists to facilitate patient enrolment. This initiative aims to make cutting-edge cancer treatments more accessible and support more equitable access to clinical trials across the region.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2805483/From_left_right__Mr_Wilson_Lai_General_Manager_Raffles_Medical.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2805483/From_left_right__Mr_Wilson_Lai_General_Manager_Raffles_Medical.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/raffles-medical-group-partners-gene-solutions-to-expand-access-to-global-cancer-clinical-trials-302595012.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGS","BSL.SI","BK6092","MRD.AU","BK4179","BK6511","BK7095","NGS.AU","BK7111"],"gpt_icon":0},{"id":"2577530256","title":"BRIEF-Mount Ridley Mines Seeks Trading Halt Pending Gallium Resource Estimate Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2577530256","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577530256?lang=en_us&edition=fundamental","pubTime":"2025-10-24 06:52","pubTimestamp":1761259938,"startTime":"0","endTime":"0","summary":"BRIEF-Mount Ridley Mines Seeks Trading Halt Pending Gallium Resource Estimate AnnouncementOct 24 (Reuters) - Mount Ridley Mines Ltd MRD.AX:TRADING HALTSEEKS TRADING HALT PENDING GALLIUM RESOURCE ESTIMATE ANNOUNCEMENTFurther company coverage: MRD.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUE90C2N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRD.AU","BK7095"],"gpt_icon":0},{"id":"2577530170","title":"Mount Ridley Mines Ltd-Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2577530170","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577530170?lang=en_us&edition=fundamental","pubTime":"2025-10-24 06:48","pubTimestamp":1761259710,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUE90C2N0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRD.AU","BK7095"],"gpt_icon":0},{"id":"2576833172","title":"Mount Ridley Mines Ltd-Proposed Issue of Securities - Mrd","url":"https://stock-news.laohu8.com/highlight/detail?id=2576833172","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576833172?lang=en_us&edition=fundamental","pubTime":"2025-10-20 15:08","pubTimestamp":1760944130,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUE9ZCHYZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7095","MRD.AU"],"gpt_icon":0},{"id":"2576833592","title":"Does Natera's (NTRA) MRD Platform Recognition Signal Strengthening Competitive Position in Precision Oncology?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576833592","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576833592?lang=en_us&edition=fundamental","pubTime":"2025-10-20 13:13","pubTimestamp":1760937181,"startTime":"0","endTime":"0","summary":"Natera, Inc. recently presented significant clinical data at the ESMO Congress 2025 in Berlin and was recognized by Fast Company for its Signatera molecular residual disease (MRD) platform, which is now ordered by more than half of U.S. oncologists.\nThese developments highlight ongoing advances in early cancer detection and underscore Natera's growing clinical importance and market influence in precision oncology.\nWe'll explore how Natera's prominent ESMO presentation and industry...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/does-nateras-ntra-mrd-platform-recognition-signal-strengthen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntra/natera/news/does-nateras-ntra-mrd-platform-recognition-signal-strengthen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","LU0012050646.USD","LU0963586101.USD","LU0345770993.USD","BK7095","MRD.AU","BK4139","LU2065171402.SGD","LU2324357040.USD","LU2065171311.SGD","LU2065731478.USD","LU0106261612.USD","NTRA","LU1988902786.USD","LU2264538146.SGD","LU1064131342.USD","LU0345770308.USD","LU2065169927.USD","LU2065170008.USD"],"gpt_icon":0},{"id":"2575723601","title":"Could NeoGenomics' (NEO) MRD Advances Redefine Its Edge in Precision Oncology?","url":"https://stock-news.laohu8.com/highlight/detail?id=2575723601","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575723601?lang=en_us&edition=fundamental","pubTime":"2025-10-16 21:23","pubTimestamp":1760621035,"startTime":"0","endTime":"0","summary":"NeoGenomics, Inc. recently presented new clinical data at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, highlighting the capabilities of its RaDaR ST molecular residual disease (MRD) assay for pharmaceutical partners in oncology research and clinical trials.\nThis development underscores the company's push to enhance precision oncology solutions, leveraging advanced circulating tumor DNA analysis to support real-time, patient-specific monitoring in cancer drug...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/could-neogenomics-neo-mrd-advances-redefine-its-edge-in-prec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-neo/neogenomics/news/could-neogenomics-neo-mrd-advances-redefine-its-edge-in-prec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MRD.AU","BK4121","NEO","BK4196","LU0012050646.USD","BK7095","LU0106261612.USD"],"gpt_icon":0},{"id":"2575767330","title":"Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2575767330","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575767330?lang=en_us&edition=fundamental","pubTime":"2025-10-16 10:30","pubTimestamp":1760581800,"startTime":"0","endTime":"0","summary":"SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- What if cancer care could move from reactive to proactive?At the Singapore Society of Oncology Annual Scientific Meeting 2025 , Gene Solutions showcased how Molecular Residual Disease  and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore's role as a hub for innovation and global collaboration.The symposium, \"Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors,\" gathered leading oncologists and molecular biology experts to explore how ctDNA-MRD and multi-omics support clinicians and researchers in Singapore and across the Asia-Pacific.MRD assays analyze circulating tumor DNA  in the blood to monitor cancer at the molecular level. Experts discussed how this approach may:. Unlike single-modality tests, Gene Solutions' platform integrates DNA, RNA, and AI-enhanced multi-omics signals for comprehensive tumor profiling and personalized ctDNA monitoring. This multi-omics appro","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/gene-solutions-brings-insights-on-advances-in-mrd-and-multi-omics-technologies-to-the-singapore-society-of-oncology-annual-scientific-meeting-2025-302585716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","MRD.AU","NGS.AU","BK7095","NGS","BK7111"],"gpt_icon":0},{"id":"2575290070","title":"Solowin Holdings to Change Nasdaq Ticker Symbol to \"AXG\" Amid Web3 Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2575290070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575290070?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:29","pubTimestamp":1760444949,"startTime":"0","endTime":"0","summary":"Solowin Holdings Ltd., a financial services firm focused on both traditional and digital assets, has adopted the new trading symbol \"AXG\" to reflect its strategic transformation towards Web3 business following the acquisition of AlloyX Limited and the development of AX Coin.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solowin Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL8J5hYX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7095","SWIN","BK4127","AXG","MRD.AU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mtridleymines.com.au","stockEarnings":[{"period":"1week","weight":-0.0882},{"period":"1month","weight":0.4091},{"period":"3month","weight":14.5},{"period":"6month","weight":14.5},{"period":"1year","weight":2.1},{"period":"ytd","weight":9.3333}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0281},{"period":"3month","weight":0.0511},{"period":"6month","weight":0.0935},{"period":"1year","weight":0.2415},{"period":"ytd","weight":0.2485}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Mount Ridley Mines Limited engages in the mineral exploration activities in Australia. The company explores for base and precious metal deposits, such as nickel, copper, cobalt, lead, zinc, silver, and gold. Its flagship project is the 100% owned Mt Ridley project that consists of four tenements located in the Albany Fraser Range region of Western Australia. The company was formerly known as AXG Mining Limited and changed its name to Mount Ridley Mines Limited in December 2014. Mount Ridley Mines Limited was incorporated in 2000 and is based in Nedlands, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.01917},{"month":2,"riseRate":0.238095,"avgChangeRate":-0.032014},{"month":3,"riseRate":0.15,"avgChangeRate":0.006879},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.081839},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.093813},{"month":6,"riseRate":0.380952,"avgChangeRate":0.206281},{"month":7,"riseRate":0.333333,"avgChangeRate":0.056664},{"month":8,"riseRate":0.190476,"avgChangeRate":-0.003379},{"month":9,"riseRate":0.454545,"avgChangeRate":0.470392},{"month":10,"riseRate":0.363636,"avgChangeRate":0.081949},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.035518},{"month":12,"riseRate":0.5,"avgChangeRate":0.049917}],"exchange":"ASX","name":"MOUNT RIDLEY MINES LTD","nameEN":"MOUNT RIDLEY MINES LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MOUNT RIDLEY MINES LTD(MRD.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MOUNT RIDLEY MINES LTD(MRD.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MOUNT RIDLEY MINES LTD,MRD.AU,MOUNT RIDLEY MINES LTD股票,MOUNT RIDLEY MINES LTD股票老虎,MOUNT RIDLEY MINES LTD股票老虎国际,MOUNT RIDLEY MINES LTD行情,MOUNT RIDLEY MINES LTD股票行情,MOUNT RIDLEY MINES LTD股价,MOUNT RIDLEY MINES LTD股市,MOUNT RIDLEY MINES LTD股票价格,MOUNT RIDLEY MINES LTD股票交易,MOUNT RIDLEY MINES LTD股票购买,MOUNT RIDLEY MINES LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MOUNT RIDLEY MINES LTD(MRD.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MOUNT RIDLEY MINES LTD(MRD.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction